Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside
Litzow, Mark R. ; Raetz, Elizabeth A.
Synopsis "Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside "
I - TRANSLATIONAL SCIENCE 1. Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia 2. Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia 3. Minimal Residual Disease in Acute Lymphoblastic Leukemia - Techniques and Application II - THERAPEUTICS 4. Treatment of Pediatric B and T cell ALL 5. Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances 6. Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL 7. Treatment of Elderly Patients with Acute Lymphoblastic Leukemia 8. Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia 9. Treatment of adult Philadelphia chromosome positive ALL 10. Treatment of Ph-like ALL 11. Prophylaxis and treatment of central nervous system (CNS) ALL 12. Late effects of therapy of acute lymphoblastic leukemia III - NEW AND EXISTING MODALITIES OF THERAPY 13. Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL 14. New Agents for the Treatment of T-Cell ALL 15. The development and management of treatment with chimeric-antigen receptor T cell (CAR-T) 16. Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL) 17. Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia